
Domvanalimab Plus Zimberelimab and Chemo Set for Phase 3 Study After Showing Efficacy in Untreated Upper GI Cancers
Domvanalimab in combination with zimberelimab and FOLFOX (leucovorin, fluorouracil, and oxaliplatin) was active with no new safety signals in patients with untreated locally advanced unresectable or metastatic gastric, gastroesophageal junction (GEJ), or …